Approved indications

• Acute herpes zoster (shingles) in immunocompetent adults.
• Recurrent episodes of genital herpes in immunocompetent adults, including episodic treatment and chronic suppressive therapy.
• Herpes labialis (cold sores) in immunocompetent adults, typically as a single-day high-dose regimen.

Off-label uses (evidence varies)

• Sometimes used off-label for herpes zoster or genital herpes in certain immunocompromised patients, and for other herpes simplex infections (e.g., oral HSV) when standard agents are not suitable; data support antiviral activity, but dosing and efficacy may be less well defined than for on-label uses.
• Other off-label uses are limited and usually reserved for specialist decision-making when acyclovir or valacyclovir cannot be used.

Efficacy expectations

• When started promptly (ideally within 48–72 hours of symptom onset), shingles pain and rash severity are reduced and lesions crust over sooner; risk of complications such as prolonged pain may also be lowered.
• For recurrent genital herpes and cold sores, treatment shortens episode duration by about 1–2 days on average and reduces viral shedding; suppressive therapy decreases outbreak frequency and can reduce transmission risk when combined with safer sex practices.
• Compared with other oral anti-herpes drugs (acyclovir, valacyclovir), famciclovir offers similar overall efficacy and safety, with some regimens allowing convenient single- or limited-day dosing, and choice among agents is often based on dosing preference, cost, and kidney function.

Typical adult dosing (oral tablets)

• Shingles (herpes zoster): commonly 500 mg three times daily for 7 days, ideally starting within 72 hours of rash onset.
• Recurrent genital herpes (episodic): often 1000 mg twice in one day (two doses 12 hours apart), or other short-course regimens as prescribed.
• Genital herpes (suppressive): lower daily doses (for example, 250 mg twice daily) are used long term to reduce recurrences.
• Cold sores (herpes labialis): a common regimen is 1500 mg taken once as a single dose at the first sign of symptoms.

How to take

• Swallow tablets whole with water; they may be taken with or without food, though taking with food can lessen stomach upset.
• Try to take doses at evenly spaced times and follow the exact schedule provided, even if symptoms start to improve early.

Special instructions

• Dose adjustments are required for people with reduced kidney function and sometimes in older adults.
• Do not double daily doses without medical advice; for suppressive therapy, do not stop suddenly without discussing with your clinician if you have frequent outbreaks.

Missed dose

• If you miss a dose and remember soon, take it as soon as possible; if it is almost time for the next dose, skip the missed dose and resume the regular schedule.
• Do not take two doses at the same time to make up for a missed dose.

Overdose

• Taking more than prescribed can increase the risk of side effects such as confusion, dizziness, or kidney problems, especially in people with kidney disease.
• In case of suspected overdose, contact emergency services or a poison control center right away, bringing the medication container if possible.

Common side effects

• Most people tolerate famciclovir well; common effects include headache, nausea, diarrhea, fatigue, and dizziness, which are usually mild to moderate and often appear within the first few days of treatment.
• Some people may notice itching, rash, or abdominal discomfort; these typically resolve after the medication is stopped.

Serious or rare adverse effects

• Allergic reactions (such as swelling of the face/lips/tongue, trouble breathing, or severe rash) are rare but require immediate emergency care.
• Very uncommon effects reported with related antivirals include confusion, hallucinations, agitation, seizures, or significant kidney problems, especially in older adults or those with severe kidney disease; sudden changes in thinking, urine output, or overall alertness warrant urgent medical attention.

Warnings and precautions

• Kidney problems: Dose reduction is needed in people with impaired kidney function to prevent drug buildup and side effects.
• Liver disease: Usually tolerated, but people with significant liver disease should be monitored more closely.
• Pregnancy and breastfeeding: Human data are limited; use is generally considered when potential benefits outweigh risks, and decisions should be individualized with a clinician.
• Age limits: Safety and effectiveness for most indications are established in adults; pediatric use is limited and typically guided by a specialist.

Relative safety profile and reporting

Famciclovir has a safety profile comparable to other oral herpes antivirals and is generally considered low risk when dosed appropriately; patients are encouraged to report bothersome or unexpected side effects to their prescriber and can submit reports to national adverse event monitoring programs or check official drug safety update sites for new safety communications.

Drug and supplement interactions

• Famciclovir has relatively few major drug interactions, but medicines that affect kidney function (for example, certain diuretics, some blood pressure drugs, or other antivirals) can increase the risk of side effects if the kidneys are already compromised.
• Combining with other drugs that are cleared by the kidneys at high doses may require closer monitoring or dose adjustments, especially in older adults or those with kidney disease.
• Most common over-the-counter pain relievers and supplements have no direct interaction, but high-dose NSAIDs or dehydrating agents may stress the kidneys when used together.

Food, alcohol, and procedures

• Food does not significantly affect absorption; the medicine can be taken with or without meals.
• Moderate alcohol intake is not known to directly interact, but alcohol can worsen dehydration and may not be advisable when acutely ill.
• No specific interactions with imaging contrast agents are typical, though people with kidney problems should always inform radiology staff and clinicians of all medications.

Precautions and monitoring

• Tell your clinician if you have kidney disease, are elderly, or are taking other nephrotoxic drugs, as dose adjustment and periodic kidney function tests may be needed.
• Inform your prescriber about all medicines and supplements, especially other antivirals, chemotherapy, or immune-suppressing drugs.
• Routine blood monitoring is not usually required in healthy adults on short courses, but longer-term suppressive therapy or use in high-risk patients may warrant periodic lab checks.

Q: Does famciclovir cure herpes or shingles permanently?
A: No; famciclovir does not eliminate the herpes viruses from your body, but it helps outbreaks heal faster, reduces symptoms, and can lower how often episodes occur when taken as suppressive therapy.

Q: How quickly will famciclovir start working?
A: The medicine begins acting soon after you take it, and people often notice less pain and slower spread of sores within 1–2 days, especially if treatment is started early in the outbreak.

Q: Can I take famciclovir only when I feel an outbreak coming on?
A: For many adults with infrequent outbreaks, doctors prescribe famciclovir as short "episodic" treatment started at the first sign of tingling, burning, or redness, but those with frequent or severe recurrences may benefit more from daily suppressive dosing.

Q: Is famciclovir better than acyclovir or valacyclovir?
A: All three are effective anti-herpes medicines with similar outcomes; famciclovir sometimes offers more convenient short-course or single-dose regimens, while the choice among them usually depends on dosing preferences, kidney function, cost, and prescriber experience.

Q: Can I stop taking famciclovir once I feel better?
A: For a short prescribed course (such as for shingles or a genital herpes episode), you should generally continue until the course is finished unless your clinician advises otherwise, as stopping early may reduce the full benefit of treatment.

Storage

Store famciclovir tablets at room temperature (generally 20°C to 25°C / 68°F to 77°F), away from excess heat, moisture, and direct light, and keep them in the original tightly closed container and out of reach of children and pets.

Disposal

Do not flush unused tablets down the toilet unless specifically instructed; instead, use a drug take-back program if available or follow local guidance for mixing unused tablets with an undesirable substance (such as used coffee grounds or cat litter), sealing in a container, and placing in household trash with personal information removed from the bottle label.